Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
Guilan Quan(Laboratoire de Chémo-biologie synthétique et thérapeutique), Chuanbin Wu(Laboratoire de Chémo-biologie synthétique et thérapeutique), Zhouhua Wang(Sun Yat-sen University), Xin Pan(Henan Normal University), Bao Chen(Sun Yat-sen University), Qiaoli Wu, Ge Li(Guangdong Pharmaceutical University), Linghui Dian(Guangdong Medical College)
Cited by 94
Related Papers
Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy
|Biomaterials|2021|1.1k
Mesoporous silica nanoparticles for drug and gene delivery
|Acta Pharmaceutica Sinica B|2018|691
Microneedle-mediated transdermal drug delivery for treating diverse skin diseases
|Acta Biomaterialia|2020|247
Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era
|Acta Pharmaceutica Sinica B|2021|176
Strategy for hypertrophic scar therapy: Improved delivery of triamcinolone acetonide using mechanically robust tip-concentrated dissolving microneedle array
|Journal of Controlled Release|2019|153